MedPath

Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012

Conditions
Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program
Registration Number
EUCTR2006-003813-42-SE
Lead Sponsor
V Organon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Subjects from whom embryos have been cryopreserved in Trial 107012 of which at least
one embryo is thawed for use in a subsequent FTET cycle;
2. Able and willing to give written informed consent.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

None.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To collect the outcome of frozen-thawed embryo transfer cycles after the embryos are cryopreserved in Trial 107012, in order to estimate the cumulative pregnancy rate for each treatment group.;Secondary Objective: ;Primary end point(s): Cumulative ongoing pregnancy rate; the cumulative ongoing pregnancy rate is the percentage of subjects who started controlled ovarian stimulation treatment in Trial 107012 and have an ongoing pregnancy either immediately after embryo transfer in Trial 107012 or after one or more frozen-thawed embryo transfer cycles following cryopreservation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath